iRhythm Technologies, Inc. (IRTC)
Automate Your Wheel Strategy on IRTC
With Tiblio's Option Bot, you can configure your own wheel strategy including IRTC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol IRTC
- Rev/Share 19.5817
- Book/Share 2.7434
- PB 53.0467
- Debt/Equity 8.4867
- CurrentRatio 5.7121
- ROIC -0.1339
- MktCap 4646088909.0
- FreeCF/Share 0.4414
- PFCF 333.2202
- PE -46.7575
- Debt/Assets 0.7942
- DivYield 0
- ROE -1.1284
- Rating D+
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | IRTC | Wells Fargo | Equal Weight | Overweight | -- | $130 | May 2, 2025 |
| Resumed | IRTC | Wells Fargo | -- | Equal Weight | -- | $86 | Dec. 3, 2024 |
| Initiation | IRTC | Goldman | -- | Neutral | -- | $78 | Oct. 4, 2024 |
News
iRhythm Technologies, Inc. (NASDAQ: IRTC) Investor Alert: Schubert Jonckheer & Kolbe LLP Investigating Possible Shareholder Claims for False Statements and Insider Trading
Published: June 17, 2025 by: PRNewsWire
Sentiment: Neutral
SAN FRANCISCO , June 17, 2025 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises iRhythm Technologies, Inc. investors that the firm is investigating potential legal claims relating to alleged false statements exaggerating the capabilities of iRhythm's wearable Zio AT heart event monitor. Current shareholders are encouraged to contact the firm.
Read More
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
Published: June 12, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IRTC.
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Investors to Connect
Published: June 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IRTC.
Read More
iRhythm Technologies, Inc. (IRTC) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Published: June 05, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / June 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IRTC.
Read More
iRhythm Technologies (IRTC) Upgraded to Buy: Here's What You Should Know
Published: March 17, 2025 by: Zacks Investment Research
Sentiment: Positive
iRhythm Technologies (IRTC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
iRhythm Technologies, Inc. (IRTC) Q4 2024 Earnings Call Transcript
Published: February 21, 2025 by: Seeking Alpha
Sentiment: Neutral
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President & CEO Daniel Wilson - CFO Conference Call Participants Macauley Kilbane - William Blair Lilia-Celine Lozada - JPMorgan Kallum Titchmarsh - Morgan Stanley Nathan Treybeck - Wells Fargo David Roman - Goldman Sachs Sam Eiber - BTIG Jon Young - Canaccord Genuity David Rescott - Baird Suraj Kalia - Oppenheimer Felipe Lamar - Truist Paige Chamberlain - Wolfe Research Operator Good afternoon. Thank you for attending today's iRhythm Technologies Q4 2024 Earnings Conference …
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Connect
Published: February 14, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IRTC.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against iRhythm Technologies, Inc. (IRTC) And Encourages Shareholders to Reach Out
Published: February 13, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / February 13, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IRTC.
Read More
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against iRhythm Technologies, Inc. (IRTC) and Encourages Investors to Learn More About the Investigation
Published: February 10, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IRTC.
Read More
About iRhythm Technologies, Inc. (IRTC)
- IPO Date 2016-10-20
- Website https://www.irhythmtech.com
- Industry Medical - Devices
- CEO Mr. Quentin S. Blackford
- Employees 2000